{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T23:56:09Z","timestamp":1793058969391,"version":"4.5.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T00:00:00Z","timestamp":1705363200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","gynecologiconcology-online.net","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ygyno.2024.01.020","type":"journal-article","created":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T23:54:18Z","timestamp":1706745258000},"page":"96-102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Variation in cervical cancer screening test utilization and results in a United States-based program"],"prefix":"10.1016","volume":"184","author":[{"given":"Vanessa G.","family":"Dorismond","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Saraiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer V.","family":"Gopalani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwini","family":"Soman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristy","family":"Kenney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George F.","family":"Sawaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2024.01.020_bb0005","series-title":"U.S. Cancer Statistics Data Visualizations Tool, based on 2020 submission data (1999\u20132018)","author":"U.S. Cancer Statistics Working Group","year":"2023"},{"key":"10.1016\/j.ygyno.2024.01.020_bb0010","author":"U.S. Preventive Services Task Force"},{"issue":"9","key":"10.1016\/j.ygyno.2024.01.020_bb0015","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.cmi.2020.03.033","article-title":"Commercially available molecular tests for human papillomaviruses: a global overview","volume":"26","author":"Poljak","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"issue":"4","key":"10.1016\/j.ygyno.2024.01.020_bb0020","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.amepre.2022.10.014","article-title":"Accelerating cervical cancer screening with human papillomavirus genotyping","volume":"64","author":"Sawaya","year":"2023","journal-title":"Am. J. Prev. Med."},{"issue":"4","key":"10.1016\/j.ygyno.2024.01.020_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2020.10.001","article-title":"Risk of cervical precancer and cancer among uninsured and underserved women from 2009 to 2017","volume":"224","author":"Saraiya","year":"2021","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2024.01.020_bb0030","author":"U.S. Department of Health and Human Services"},{"issue":"2","key":"10.1016\/j.ygyno.2024.01.020_bb0035","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1089\/jwh.2018.7380","article-title":"Trends over time in pap and pap-HPV Cotesting for cervical Cancer screening","volume":"28","author":"MacLaughlin","year":"2019","journal-title":"J. Women\u2019s Health (Larchmt)"},{"issue":"2","key":"10.1016\/j.ygyno.2024.01.020_bb0040","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ygyno.2021.08.023","article-title":"Trends in the use of cervical cancer screening tests in a large medical claims database, United States, 2013-2019","volume":"163","author":"Qin","year":"2021","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2024.01.020_bb0045","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/LGT.0000000000000558","article-title":"Assessing physician adherence to guidelines for cervical cancer screening and management of abnormal screening results","volume":"24","author":"Min","year":"2020","journal-title":"J. Low. Genit. Tract Dis."},{"key":"10.1016\/j.ygyno.2024.01.020_bb0050","doi-asserted-by":"crossref","first-page":"106014","DOI":"10.1016\/j.ypmed.2020.106014","article-title":"Geographic and sociodemographic differences in cervical cancer screening modalities","volume":"133","author":"Goding Sauer","year":"2020","journal-title":"Prev. Med."},{"key":"10.1016\/j.ygyno.2024.01.020_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2021.106871","article-title":"Variation in the receipt of human papilloma virus co-testing for cervical screening: individual, provider, facility and healthcare system characteristics","volume":"154","author":"Haas","year":"2022","journal-title":"Prev. Med."},{"issue":"6","key":"10.1016\/j.ygyno.2024.01.020_bb0060","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1002\/ijc.31940","article-title":"Cervical cancer screening research in the PROSPR I consortium: Rationale, methods and baseline findings from a US cohort","volume":"144","author":"Kamineni","year":"2019","journal-title":"Int. J. Cancer"},{"issue":"14","key":"10.1016\/j.ygyno.2024.01.020_bb0065","doi-asserted-by":"crossref","first-page":"5272","DOI":"10.1002\/cam4.3125","article-title":"Geographical disparities in human papillomavirus herd protection","volume":"9","author":"Berenson","year":"2020","journal-title":"Cancer Med."},{"issue":"30","key":"10.1016\/j.ygyno.2024.01.020_bb0070","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1016\/j.vaccine.2019.06.001","article-title":"Regional variations in human papillomavirus prevalence across time in NHANES (2003\u20132014)","volume":"37","author":"Hirth","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.ygyno.2024.01.020_bb0075","series-title":"HIV Diagnosis","author":"HIV in the United States by Region","year":"2023"},{"key":"10.1016\/j.ygyno.2024.01.020_bb0080","author":"The HPV Vaccine"},{"key":"10.1016\/j.ygyno.2024.01.020_bb0085","series-title":"The American Cancer Society Guidelines for the Prevention and Early Detection of Cervical Cancer","author":"The American Cancer Society medical and editorial content team","year":"2021"},{"issue":"5","key":"10.1016\/j.ygyno.2024.01.020_bb0090","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3322\/caac.21628","article-title":"Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society","volume":"70","author":"Fontham","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ygyno.2024.01.020_bb0095","series-title":"WHO Guideline for Screening and Treatment of Cervical Pre-cancer Lesions for Cervical cancer Prevention","year":"2021"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825824000337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825824000337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T16:49:54Z","timestamp":1726246194000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825824000337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":19,"alternative-id":["S0090825824000337"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2024.01.020","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Variation in cervical cancer screening test utilization and results in a United States-based program","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2024.01.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}